The number of Medicare Part D beneficiaries who reach the catastrophic coverage phase of the prescription drug benefit rose by more than 50% between 2013 and 2016, according to an analysis released today by Avalere. The study looked at the 72% of Part D beneficiaries who do not receive low-income subsidies and found more than 800,000 entered the catastrophic coverage phase in 2016, up from about 515,000 in 2013. “Beneficiaries who reach the catastrophic coverage phase have spent thousands of dollars out-of-pocket on prescription drugs,” said Avalere President Dan Mendelson. “Because Part D has no out-of-pocket maximum, these patients will continue to face additional costs throughout the year.” Once in catastrophic coverage, beneficiaries pay up to 5% of their drug costs while the government pays 80% and the Part D plan 15%.

Related News Articles

Headline
A Health Affairs study published Sept. 2 found that less than 40% of Medicare beneficiaries with opioid use disorder received standard care in alignment with…
Headline
The AHA Sept. 3 released a study conducted by KNG Health Consulting that found Medicare patients who receive care in a hospital outpatient department are more…
Headline
The AHA Aug. 28 expressed support for the Preserving Patient Access to Accountable Care Act in comments to House and Senate sponsors of the bill. The…
Headline
The Department of Health and Human Services and the Centers for Medicare & Medicaid Services Aug. 21 announced the creation of a Healthcare Advisory…
Headline
A JAMA study published Aug. 18 found that plan design changes by Medicare Part D insurers, particularly for Medicare Advantage plans, following passage of the…
Headline
The AHA on Aug. 14 at 1 p.m. ET will host a webinar on age-friendly health systems and how they can strengthen care delivery. Adam Koontz, senior director of…